158 related articles for article (PubMed ID: 8685466)
1. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
2. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
4. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
6. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.
Abrahamsen AF; Lien HH; Aas M; Winderen M; Hager B; Kvaløy S; Elgjo RF; Nome O
Ann Oncol; 1994 May; 5(5):433-6. PubMed ID: 8075050
[TBL] [Abstract][Full Text] [Related]
8. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
[TBL] [Abstract][Full Text] [Related]
9. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
[No Abstract] [Full Text] [Related]
10. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
[TBL] [Abstract][Full Text] [Related]
11. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy.
Ruíz Hernández G; Pallardó Y; García Conde J; Ramos D; Ampudia J; Castillo FJ; Romero C
Nuklearmedizin; 1999 Apr; 38(3):90-4. PubMed ID: 10320995
[TBL] [Abstract][Full Text] [Related]
13. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
15. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
Harris EW; Rakow JI; Weiner M; Agress H
J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
[TBL] [Abstract][Full Text] [Related]
16. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
17. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
[TBL] [Abstract][Full Text] [Related]
18. Role of 67Ga scintigraphy in localization of lymphoma.
van Amsterdam JA; Kluin-Nelemans JC; van Eck-Smit BL; Pauwels EK
Ann Hematol; 1996 Apr; 72(4):202-7. PubMed ID: 8624373
[TBL] [Abstract][Full Text] [Related]
19. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
[TBL] [Abstract][Full Text] [Related]
20. The value of thoracic computed tomography in the detection of recurrent Hodgkin's disease.
Heron CW; Husband JE; Williams MP; Cherryman GR
Br J Radiol; 1988 Jul; 61(727):567-72. PubMed ID: 3408843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
